Overview
Clinical Benefits
- Significant weight loss
- Appetite suppression
- Blood sugar control
- Cardiovascular benefits
Administration
Subcutaneous injection — abdomen, thigh, or upper arm
Drug class: glp1 agonist
Clinical Dosing
Typical dosage
0.25mg starting, titrate up to 2.4mg
Starting dose
0.25mg
Cadence
Once weekly
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-4 | 0.25mg once weekly |
| Weeks 5-8 | 0.5mg once weekly |
| Weeks 9-12 | 1.0mg once weekly |
| Weeks 13-16 | 1.7mg once weekly |
| Weeks 17+ | 2.4mg once weekly (maintenance) |
Safety Profile
Side effects
- • Nausea (most common at dose increases)
- • Vomiting
- • Diarrhea
- • Constipation
Contraindications
- • Medullary thyroid carcinoma
- • MEN 2 syndrome
- • Pancreatitis history
Do not combine with
Frequently asked questions
Semaglutide is most commonly researched for: Significant weight loss, Appetite suppression, Blood sugar control, Cardiovascular benefits.
Ready to build a protocol with Semaglutide?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.